Tag: Alzheimers
Eli Lilly to take big swings in Alzheimer’s, ALS and gene therapy
Heart disease. Hearing loss. Addiction. Chronic pain. Alzheimer's. ALS. These are some of the areas where Eli Lilly, flush with cash from its GLP-1 dr [...]
Schizophrenia drug Cobenfy could treat Alzheimer’s
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam Glan [...]
Leqembi could give Alzheimer’s patients more time, but road to treatment is long
Hannah Yoon | The Washington Post | Getty ImagesLeqembi, an Alzheimer's drug from Biogen and Eisai, isn't a cure for the mind-damaging disease. But t [...]
Eisai Biogen Alzheimer’s drug Leqembi shows benefits over three years
The newly FDA approved Alzheimer's treatment Leqembi is prepared at Abington Neurological Associates in Abington, PA., on Tuesday, November 7, 2023. H [...]
Novo Nordisk GLP-1 liraglutide may slow Alzheimer’s progression
A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter at a pharmacy in Provo, Utah, January 9, 2020.George Frey | ReutersA [...]
FDA approves Eli Lilly Alzheimer’s drug donanemab
A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana.Scott Olson | [...]
FDA advisors recommend Eli Lilly Alzheimer’s drug donanemab
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.'s shares climbed in early US trading after its exp [...]
Eli Lilly Alzheimer’s drug FDA approval delayed
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.'s shares climbed in early US trading after its exp [...]
Biogen drops Alzheimer’s drug Aduhelm to focus on Leqembi, others
The Biogen headquarters in Cambridge, Massachusetts, on Tuesday, Oct. 24, 2023.Vanessa Leroy | Bloomberg | Getty ImagesBiogen on Wednesday said it wil [...]
Alzheimer’s drug Leqembi shows promise as injection
Eisai on Wednesday said an injectable version of the Alzheimer's drug Leqembi showed promising initial results in a clinical trial, potentially paving [...]
Alzheimer’s drug Leqembi sales may be slow at first: Analysts
Jay Reinstein, who suffers from Alzheimer's, receives an injection so he can have a PET scan at MedStar Georgetown University Hospital in Washington, [...]
FDA approves Alzheimer’s drug Leqembi from Eisai, Biogen
The Food and Drug Administration on Thursday approved the Alzheimer's treatment Leqembi, a pivotal decision that is expected to expand access to the e [...]
States urge Medicare to cover Alzheimer’s treatments
Democratic and Republican attorneys general in nearly half of U.S. states are calling on Medicare to provide unrestricted coverage of antibody treatme [...]
Biogen not worried about Alzheimer’s competition with Eli Lilly
A person skateboards past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021.Adam Glanzman | Bloomberg | Getty ImagesBiogen [...]
Lecanemab, a new Alzheimer’s drug, could soon get FDA approval. Does it actually work?
A new Alzheimer’s medication appears to be on the verge of approval by the US Food and Drug Administration. But such a major milestone, given the p [...]